Company Overview of Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company’s lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its Entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. The company has a collaborative research and development agreement with the National Cancer Institute. Syndax Pharmaceuticals, Inc. was founded ...
400 Totten Pond Road
Waltham, MA 02451
Founded in 2005
Key Executives for Syndax Pharmaceuticals, Inc.
Chief Executive Officer and Director
President and Chief Operating Officer
Co-Founder and Chief Technology Officer
Compensation as of Fiscal Year 2015.
Syndax Pharmaceuticals, Inc. Key Developments
Syndax Pharmaceuticals Announces Management Changes
Jun 23 15
Syndax Pharmaceuticals has named Briggs Morrison as CEO and a member of the board, and Michael Metzger as president and COO. Morrison joins Syndax from AstraZeneca, where he was chief medical officer. He replaces Arlene Morris in the CEO role, who left in May to pursue other endeavors, said a company spokeswoman. Metzger joins from Regado Biosciences, where he was president and CEO through the company's strategic merger with Tobira Therapeutics.
Briggs Morrison to Join Syndax Pharmaceuticals as Head of Global Late-Stage Drug Development
Jun 15 15
Outgoing Chief Medical Officer of AstraZeneca Briggs Morrison will join Syndax Pharmaceuticals. Morrison, who joined the pharmaceutical company in 2012, is also serving the company as head of global late-stage drug development.
Syndax Pharmaceuticals, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:00 PM
May 7 15
Syndax Pharmaceuticals, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:00 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 1, 2015
January 7, 2015
September 18, 2014
Most Searched Private Companies
Sponsored Financial Commentaries